Last C$0.45 CAD
Change Today -0.01 / -2.17%
Volume 12.5K
TPI On Other Exchanges
Symbol
Exchange
Venture
As of 12:17 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

t-bird pharma inc (TPI) Snapshot

Open
C$0.47
Previous Close
C$0.46
Day High
C$0.47
Day Low
C$0.43
52 Week High
09/9/14 - C$0.95
52 Week Low
12/12/14 - C$0.43
Market Cap
20.7M
Average Volume 10 Days
50.3K
EPS TTM
C$-0.15
Shares Outstanding
46.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for T-BIRD PHARMA INC (TPI)

Related News

No related news articles were found.

t-bird pharma inc (TPI) Related Businessweek News

No Related Businessweek News Found

t-bird pharma inc (TPI) Details

T-Bird Pharma Inc. operates as a pharmaceutical company in Canada. It primarily focuses on developing medical marijuana products. The company is based in White City, Canada.

t-bird pharma inc (TPI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

t-bird pharma inc (TPI) Key Developments

T-Bird Pharma Inc. Appoints Bin Huang as President and Chief Operating Officer

T-Bird Pharma Inc. announced that Dr. Bin Huang has joined the company as President and Chief Operating Officer. Dr. Huang joins the company as a key part of its growth and commercialization strategy.

Thunderbird Biomedical Inc. Signs Definitive Lease Agreement for Second Facility in Victoria, BC

T-Bird Pharma Inc. announced that its subsidiary, Thunderbird Biomedical Inc., has signed a definitive lease agreement for a second facility located in Victoria, BC. The facility has 28,966 square feet of floor space with the option to add approximately 14,500 square feet of mezzanine space for a total of approximately 43,500 square feet. Architectural and engineering work has started and the company expects infrastructure work to commence in October. Based on the time required for municipal permitting and construction, Thunderbird aims to have the first Health Canada inspection of the new facility in the first quarter of 2015. Upon completion of the first phase of construction at the facility and licensing by Health Canada the increase in growing capacity will be clearly significant. The Company will continue to provide updates on the progress of the second facility over the coming months.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TPI:CN C$0.45 CAD -0.01

TPI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TPI.
View Industry Companies
 

Industry Analysis

TPI

Industry Average

Valuation TPI Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact T-BIRD PHARMA INC, please visit www.tbirdpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.